Additional file 6 of The Q/R editing site of AMPA receptor GluA2 subunit acts as an epigenetic switch regulating dendritic spines, neurodegeneration and cognitive deficits in Alzheimer’s disease
posted on 2023-09-30, 03:22authored byAmanda L. Wright, Lyndsey M. Konen, Bruce G. Mockett, Gary P. Morris, Anurag Singh, Lisseth Estefania Burbano, Luke Milham, Monica Hoang, Raphael Zinn, Rose Chesworth, Richard P. Tan, Gordon A. Royle, Ian Clark, Steven Petrou, Wickliffe C. Abraham, Bryce Vissel
Additional file 6: Sup Figure 6. Genetically encoding GluA2(R) in J20 mice does not prevent neuroinflammation. (a) Representative images and stereological quantification revealed no changes were observed in the population of GFAP+ astrocytes within the CA1 and CA3 hippocampal regions (CA1 ANOVA F(3,16) = 0.39 p = 0.76 and CA3 ANOVA F(3,16) = 2.27 p = 0.12; n = 5/genotype). (b) Representative images and stereological quantification of CD68+ microglia in the hippocampus demonstrated a significant increase in both J20 and GluA2G/G/J20 animals when compared to WT and GluA2G/G mice (Kruskal-Wallis = 21.52 p <0.0001; n = 8 for WT and n = 7 for all other genotypes). (c) An ELISA revealed TNF protein expression in the hippocampus is significantly upregulated in J20 mice compared to WTs and this was not prevented in the GluA2G/G/J20 mice (ANOVA F(3,28) = 8.65 p <0.001; n = 8/genotype). Each value represents the mean ± the SD. *p<0.05, **p<0.01, ***p<0.001.
Funding
National Health and Medical Research Council The Boyarsky Family Trust The Howland-Rose Foundation Douglas and Alison Battersby - Veruse Pty Ltd David and Lynn King John and Debbie Schaffer Lady Fairfax Charitable Trust Stanley and Charmaine Roth Foundation Iain Gray